aluates Reports

$ 0.0

Automative

Global Viral Vector Manufacturing CDMO Services Market Research Report 2024

Published Date: January 2025

Report Code: QYRE-Auto-22J18649

BUY CHAPTERS

Global Viral Vector Manufacturing CDMO Services Market Research Report 2024

Code: QYRE-Auto-22J18649

Report

January 2025

Pages:104

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Companies

Thermo Fisher Scientific Inc

Revvity

Charles River Laboratories

Lonza

Avid Bioservices Inc.

Exothera

Merck KGaA

Batavia Biosciences

Biovian

Esco Aster

ABL, Inc.

Genezen

Pharmaron

Roche

FinVector

FUJIFILM Diosynth Biotechnologies

Kaneka Eurogentec S.A (Kaneka Corporation)

Oxford BioMedica Plc

Sanofi

AGC Inc. Group (AGC Biologics)

NorthX Biologics

SK pharmteco Inc.

Curia Vector Technology

Viral Vector Manufacturing CDMO Services Market Size

The global market for Viral Vector Manufacturing CDMO Services was valued at US$ 5231 million in the year 2023 and is projected to reach a revised size of US$ 9450 million by 2030, growing at a CAGR of 9.2% during the forecast period.

Viral Vector Manufacturing CDMO Services Market

Viral Vector Manufacturing CDMO services refer to providing professional viral vector production and development services to biopharmaceutical companies. These viral vectors are usually used in gene therapy, vaccine development, cell therapy and other fields. CDMO organizations are responsible for the design and optimization of viral vectors to large-scale production in accordance with GMP standards, ensuring the safety and effectiveness of the products, while strictly controlling the quality of each production link. These services provide key technical support for biopharmaceutical companies to help accelerate the development and commercialization of their products.

North American market for Viral Vector Manufacturing CDMO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Viral Vector Manufacturing CDMO Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Viral Vector Manufacturing CDMO Services in Gene Therapy is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Viral Vector Manufacturing CDMO Services include Thermo Fisher Scientific Inc., Revvity, Charles River Laboratories, AGC Inc. Group (AGC Biologics), NorthX Biologics, Lonza, Avid Bioservices, Inc., Exothera, Merck KGaA, Batavia Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Viral Vector Manufacturing CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Manufacturing CDMO Services.

The Viral Vector Manufacturing CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Vector Manufacturing CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Viral Vector Manufacturing CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Viral Vector Manufacturing CDMO Services Market Report

Report Metric	Details
Report Name	Viral Vector Manufacturing CDMO Services Market
Accounted market size in year	US$ 5231 million
Forecasted market size in 2030	US$ 9450 million
CAGR	9.2%
Base Year	year
Forecasted years	2025 - 2030
Segment by Type	Adeno-associated Virus Lentivirus Retrovirus Adenovirus Other
Segment by Application	Gene Therapy Vaccine Development Cell Therapy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific Inc., Revvity, Charles River Laboratories, AGC Inc. Group (AGC Biologics), NorthX Biologics, Lonza, Avid Bioservices, Inc., Exothera, Merck KGaA, Batavia Biosciences, SK pharmteco Inc., Biovian, Curia Vector Technology, Esco Aster, ABL, Inc., Genezen, Pharmaron, Roche AG, FinVector, FUJIFILM Diosynth Biotechnologies, Kaneka Eurogentec S.A. (Kaneka Corporation), Oxford Biomedica plc, Sanofi S.A.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Vector Manufacturing CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Viral Vector Manufacturing CDMO Services Market growing?

Ans: The Viral Vector Manufacturing CDMO Services Market witnessing a CAGR of 9.2% during the forecast period 2025-2030.

What is the Viral Vector Manufacturing CDMO Services Market size in 2030?

Ans: The Viral Vector Manufacturing CDMO Services Market size in 2030 will be US$ 9450 million.

Who are the main players in the Viral Vector Manufacturing CDMO Services Market report?

Ans: The main players in the Viral Vector Manufacturing CDMO Services Market are Thermo Fisher Scientific Inc., Revvity, Charles River Laboratories, AGC Inc. Group (AGC Biologics), NorthX Biologics, Lonza, Avid Bioservices, Inc., Exothera, Merck KGaA, Batavia Biosciences, SK pharmteco Inc., Biovian, Curia Vector Technology, Esco Aster, ABL, Inc., Genezen, Pharmaron, Roche AG, FinVector, FUJIFILM Diosynth Biotechnologies, Kaneka Eurogentec S.A. (Kaneka Corporation), Oxford Biomedica plc, Sanofi S.A.

What are the Application segmentation covered in the Viral Vector Manufacturing CDMO Services Market report?

Ans: The Applications covered in the Viral Vector Manufacturing CDMO Services Market report are Gene Therapy, Vaccine Development, Cell Therapy

What are the Type segmentation covered in the Viral Vector Manufacturing CDMO Services Market report?

Ans: The Types covered in the Viral Vector Manufacturing CDMO Services Market report are Adeno-associated Virus, Lentivirus, Retrovirus, Adenovirus, Other

Recommended Reports

CDMO Services

Advanced Therapeutics

Biologics & Drug CDMO

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Viral Vector Manufacturing CDMO Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Adeno-associated Virus

1.2.3 Lentivirus

1.2.4 Retrovirus

1.2.5 Adenovirus

1.2.6 Other

1.3 Market by Application

1.3.1 Global Viral Vector Manufacturing CDMO Services Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Gene Therapy

1.3.3 Vaccine Development

1.3.4 Cell Therapy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Viral Vector Manufacturing CDMO Services Market Perspective (2019-2030)

2.2 Global Viral Vector Manufacturing CDMO Services Growth Trends by Region

2.2.1 Global Viral Vector Manufacturing CDMO Services Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Viral Vector Manufacturing CDMO Services Historic Market Size by Region (2019-2024)

2.2.3 Viral Vector Manufacturing CDMO Services Forecasted Market Size by Region (2025-2030)

2.3 Viral Vector Manufacturing CDMO Services Market Dynamics

2.3.1 Viral Vector Manufacturing CDMO Services Industry Trends

2.3.2 Viral Vector Manufacturing CDMO Services Market Drivers

2.3.3 Viral Vector Manufacturing CDMO Services Market Challenges

2.3.4 Viral Vector Manufacturing CDMO Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Viral Vector Manufacturing CDMO Services Players by Revenue

3.1.1 Global Top Viral Vector Manufacturing CDMO Services Players by Revenue (2019-2024)

3.1.2 Global Viral Vector Manufacturing CDMO Services Revenue Market Share by Players (2019-2024)

3.2 Global Viral Vector Manufacturing CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Viral Vector Manufacturing CDMO Services Revenue

3.4 Global Viral Vector Manufacturing CDMO Services Market Concentration Ratio

3.4.1 Global Viral Vector Manufacturing CDMO Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Viral Vector Manufacturing CDMO Services Revenue in 2023

3.5 Global Key Players of Viral Vector Manufacturing CDMO Services Head office and Area Served

3.6 Global Key Players of Viral Vector Manufacturing CDMO Services, Product and Application

3.7 Global Key Players of Viral Vector Manufacturing CDMO Services, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Vector Manufacturing CDMO Services Breakdown Data by Type

4.1 Global Viral Vector Manufacturing CDMO Services Historic Market Size by Type (2019-2024)

4.2 Global Viral Vector Manufacturing CDMO Services Forecasted Market Size by Type (2025-2030)

5 Viral Vector Manufacturing CDMO Services Breakdown Data by Application

5.1 Global Viral Vector Manufacturing CDMO Services Historic Market Size by Application (2019-2024)

5.2 Global Viral Vector Manufacturing CDMO Services Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Viral Vector Manufacturing CDMO Services Market Size (2019-2030)

6.2 North America Viral Vector Manufacturing CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024)

6.4 North America Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Viral Vector Manufacturing CDMO Services Market Size (2019-2030)

7.2 Europe Viral Vector Manufacturing CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024)

7.4 Europe Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size (2019-2030)

8.2 Asia-Pacific Viral Vector Manufacturing CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size by Region (2019-2024)

8.4 Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Viral Vector Manufacturing CDMO Services Market Size (2019-2030)

9.2 Latin America Viral Vector Manufacturing CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024)

9.4 Latin America Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size (2019-2030)

10.2 Middle East & Africa Viral Vector Manufacturing CDMO Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024)

10.4 Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific Inc.

11.1.1 Thermo Fisher Scientific Inc. Company Details

11.1.2 Thermo Fisher Scientific Inc. Business Overview

11.1.3 Thermo Fisher Scientific Inc. Viral Vector Manufacturing CDMO Services Introduction

11.1.4 Thermo Fisher Scientific Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.1.5 Thermo Fisher Scientific Inc. Recent Development

11.2 Revvity

11.2.1 Revvity Company Details

11.2.2 Revvity Business Overview

11.2.3 Revvity Viral Vector Manufacturing CDMO Services Introduction

11.2.4 Revvity Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.2.5 Revvity Recent Development

11.3 Charles River Laboratories

11.3.1 Charles River Laboratories Company Details

11.3.2 Charles River Laboratories Business Overview

11.3.3 Charles River Laboratories Viral Vector Manufacturing CDMO Services Introduction

11.3.4 Charles River Laboratories Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.3.5 Charles River Laboratories Recent Development

11.4 AGC Inc. Group (AGC Biologics)

11.4.1 AGC Inc. Group (AGC Biologics) Company Details

11.4.2 AGC Inc. Group (AGC Biologics) Business Overview

11.4.3 AGC Inc. Group (AGC Biologics) Viral Vector Manufacturing CDMO Services Introduction

11.4.4 AGC Inc. Group (AGC Biologics) Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.4.5 AGC Inc. Group (AGC Biologics) Recent Development

11.5 NorthX Biologics

11.5.1 NorthX Biologics Company Details

11.5.2 NorthX Biologics Business Overview

11.5.3 NorthX Biologics Viral Vector Manufacturing CDMO Services Introduction

11.5.4 NorthX Biologics Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.5.5 NorthX Biologics Recent Development

11.6 Lonza

11.6.1 Lonza Company Details

11.6.2 Lonza Business Overview

11.6.3 Lonza Viral Vector Manufacturing CDMO Services Introduction

11.6.4 Lonza Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.6.5 Lonza Recent Development

11.7 Avid Bioservices, Inc.

11.7.1 Avid Bioservices, Inc. Company Details

11.7.2 Avid Bioservices, Inc. Business Overview

11.7.3 Avid Bioservices, Inc. Viral Vector Manufacturing CDMO Services Introduction

11.7.4 Avid Bioservices, Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.7.5 Avid Bioservices, Inc. Recent Development

11.8 Exothera

11.8.1 Exothera Company Details

11.8.2 Exothera Business Overview

11.8.3 Exothera Viral Vector Manufacturing CDMO Services Introduction

11.8.4 Exothera Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.8.5 Exothera Recent Development

11.9 Merck KGaA

11.9.1 Merck KGaA Company Details

11.9.2 Merck KGaA Business Overview

11.9.3 Merck KGaA Viral Vector Manufacturing CDMO Services Introduction

11.9.4 Merck KGaA Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.9.5 Merck KGaA Recent Development

11.10 Batavia Biosciences

11.10.1 Batavia Biosciences Company Details

11.10.2 Batavia Biosciences Business Overview

11.10.3 Batavia Biosciences Viral Vector Manufacturing CDMO Services Introduction

11.10.4 Batavia Biosciences Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.10.5 Batavia Biosciences Recent Development

11.11 SK pharmteco Inc.

11.11.1 SK pharmteco Inc. Company Details

11.11.2 SK pharmteco Inc. Business Overview

11.11.3 SK pharmteco Inc. Viral Vector Manufacturing CDMO Services Introduction

11.11.4 SK pharmteco Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.11.5 SK pharmteco Inc. Recent Development

11.12 Biovian

11.12.1 Biovian Company Details

11.12.2 Biovian Business Overview

11.12.3 Biovian Viral Vector Manufacturing CDMO Services Introduction

11.12.4 Biovian Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.12.5 Biovian Recent Development

11.13 Curia Vector Technology

11.13.1 Curia Vector Technology Company Details

11.13.2 Curia Vector Technology Business Overview

11.13.3 Curia Vector Technology Viral Vector Manufacturing CDMO Services Introduction

11.13.4 Curia Vector Technology Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.13.5 Curia Vector Technology Recent Development

11.14 Esco Aster

11.14.1 Esco Aster Company Details

11.14.2 Esco Aster Business Overview

11.14.3 Esco Aster Viral Vector Manufacturing CDMO Services Introduction

11.14.4 Esco Aster Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.14.5 Esco Aster Recent Development

11.15 ABL, Inc.

11.15.1 ABL, Inc. Company Details

11.15.2 ABL, Inc. Business Overview

11.15.3 ABL, Inc. Viral Vector Manufacturing CDMO Services Introduction

11.15.4 ABL, Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.15.5 ABL, Inc. Recent Development

11.16 Genezen

11.16.1 Genezen Company Details

11.16.2 Genezen Business Overview

11.16.3 Genezen Viral Vector Manufacturing CDMO Services Introduction

11.16.4 Genezen Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.16.5 Genezen Recent Development

11.17 Pharmaron

11.17.1 Pharmaron Company Details

11.17.2 Pharmaron Business Overview

11.17.3 Pharmaron Viral Vector Manufacturing CDMO Services Introduction

11.17.4 Pharmaron Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.17.5 Pharmaron Recent Development

11.18 Roche AG

11.18.1 Roche AG Company Details

11.18.2 Roche AG Business Overview

11.18.3 Roche AG Viral Vector Manufacturing CDMO Services Introduction

11.18.4 Roche AG Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.18.5 Roche AG Recent Development

11.19 FinVector

11.19.1 FinVector Company Details

11.19.2 FinVector Business Overview

11.19.3 FinVector Viral Vector Manufacturing CDMO Services Introduction

11.19.4 FinVector Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.19.5 FinVector Recent Development

11.20 FUJIFILM Diosynth Biotechnologies

11.20.1 FUJIFILM Diosynth Biotechnologies Company Details

11.20.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.20.3 FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing CDMO Services Introduction

11.20.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.20.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.21 Kaneka Eurogentec S.A. (Kaneka Corporation)

11.21.1 Kaneka Eurogentec S.A. (Kaneka Corporation) Company Details

11.21.2 Kaneka Eurogentec S.A. (Kaneka Corporation) Business Overview

11.21.3 Kaneka Eurogentec S.A. (Kaneka Corporation) Viral Vector Manufacturing CDMO Services Introduction

11.21.4 Kaneka Eurogentec S.A. (Kaneka Corporation) Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.21.5 Kaneka Eurogentec S.A. (Kaneka Corporation) Recent Development

11.22 Oxford Biomedica plc

11.22.1 Oxford Biomedica plc Company Details

11.22.2 Oxford Biomedica plc Business Overview

11.22.3 Oxford Biomedica plc Viral Vector Manufacturing CDMO Services Introduction

11.22.4 Oxford Biomedica plc Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.22.5 Oxford Biomedica plc Recent Development

11.23 Sanofi S.A.

11.23.1 Sanofi S.A. Company Details

11.23.2 Sanofi S.A. Business Overview

11.23.3 Sanofi S.A. Viral Vector Manufacturing CDMO Services Introduction

11.23.4 Sanofi S.A. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024)

11.23.5 Sanofi S.A. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Companies

Thermo Fisher Scientific Inc

Revvity

Charles River Laboratories

Lonza

Avid Bioservices Inc.

Exothera

Merck KGaA

Batavia Biosciences

Biovian

Esco Aster

ABL, Inc.

Genezen

Pharmaron

Roche

FinVector

FUJIFILM Diosynth Biotechnologies

Kaneka Eurogentec S.A (Kaneka Corporation)

Oxford BioMedica Plc

Sanofi

AGC Inc. Group (AGC Biologics)

NorthX Biologics

SK pharmteco Inc.

Curia Vector Technology

List of Tables

Table 1. Global Viral Vector Manufacturing CDMO Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Adeno-associated Virus

Table 3. Key Players of Lentivirus

Table 4. Key Players of Retrovirus

Table 5. Key Players of Adenovirus

Table 6. Key Players of Other

Table 7. Global Viral Vector Manufacturing CDMO Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Viral Vector Manufacturing CDMO Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Viral Vector Manufacturing CDMO Services Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Viral Vector Manufacturing CDMO Services Market Share by Region (2019-2024)

Table 11. Global Viral Vector Manufacturing CDMO Services Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Viral Vector Manufacturing CDMO Services Market Share by Region (2025-2030)

Table 13. Viral Vector Manufacturing CDMO Services Market Trends

Table 14. Viral Vector Manufacturing CDMO Services Market Drivers

Table 15. Viral Vector Manufacturing CDMO Services Market Challenges

Table 16. Viral Vector Manufacturing CDMO Services Market Restraints

Table 17. Global Viral Vector Manufacturing CDMO Services Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Viral Vector Manufacturing CDMO Services Market Share by Players (2019-2024)

Table 19. Global Top Viral Vector Manufacturing CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing CDMO Services as of 2023)

Table 20. Ranking of Global Top Viral Vector Manufacturing CDMO Services Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Viral Vector Manufacturing CDMO Services Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Viral Vector Manufacturing CDMO Services, Headquarters and Area Served

Table 23. Global Key Players of Viral Vector Manufacturing CDMO Services, Product and Application

Table 24. Global Key Players of Viral Vector Manufacturing CDMO Services, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Viral Vector Manufacturing CDMO Services Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Viral Vector Manufacturing CDMO Services Revenue Market Share by Type (2019-2024)

Table 28. Global Viral Vector Manufacturing CDMO Services Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Viral Vector Manufacturing CDMO Services Revenue Market Share by Type (2025-2030)

Table 30. Global Viral Vector Manufacturing CDMO Services Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Viral Vector Manufacturing CDMO Services Revenue Market Share by Application (2019-2024)

Table 32. Global Viral Vector Manufacturing CDMO Services Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Viral Vector Manufacturing CDMO Services Revenue Market Share by Application (2025-2030)

Table 34. North America Viral Vector Manufacturing CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Viral Vector Manufacturing CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Viral Vector Manufacturing CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size by Country (2025-2030) & (US$ Million)

Table 49. Thermo Fisher Scientific Inc. Company Details

Table 50. Thermo Fisher Scientific Inc. Business Overview

Table 51. Thermo Fisher Scientific Inc. Viral Vector Manufacturing CDMO Services Product

Table 52. Thermo Fisher Scientific Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 53. Thermo Fisher Scientific Inc. Recent Development

Table 54. Revvity Company Details

Table 55. Revvity Business Overview

Table 56. Revvity Viral Vector Manufacturing CDMO Services Product

Table 57. Revvity Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 58. Revvity Recent Development

Table 59. Charles River Laboratories Company Details

Table 60. Charles River Laboratories Business Overview

Table 61. Charles River Laboratories Viral Vector Manufacturing CDMO Services Product

Table 62. Charles River Laboratories Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 63. Charles River Laboratories Recent Development

Table 64. AGC Inc. Group (AGC Biologics) Company Details

Table 65. AGC Inc. Group (AGC Biologics) Business Overview

Table 66. AGC Inc. Group (AGC Biologics) Viral Vector Manufacturing CDMO Services Product

Table 67. AGC Inc. Group (AGC Biologics) Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 68. AGC Inc. Group (AGC Biologics) Recent Development

Table 69. NorthX Biologics Company Details

Table 70. NorthX Biologics Business Overview

Table 71. NorthX Biologics Viral Vector Manufacturing CDMO Services Product

Table 72. NorthX Biologics Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 73. NorthX Biologics Recent Development

Table 74. Lonza Company Details

Table 75. Lonza Business Overview

Table 76. Lonza Viral Vector Manufacturing CDMO Services Product

Table 77. Lonza Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 78. Lonza Recent Development

Table 79. Avid Bioservices, Inc. Company Details

Table 80. Avid Bioservices, Inc. Business Overview

Table 81. Avid Bioservices, Inc. Viral Vector Manufacturing CDMO Services Product

Table 82. Avid Bioservices, Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 83. Avid Bioservices, Inc. Recent Development

Table 84. Exothera Company Details

Table 85. Exothera Business Overview

Table 86. Exothera Viral Vector Manufacturing CDMO Services Product

Table 87. Exothera Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 88. Exothera Recent Development

Table 89. Merck KGaA Company Details

Table 90. Merck KGaA Business Overview

Table 91. Merck KGaA Viral Vector Manufacturing CDMO Services Product

Table 92. Merck KGaA Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 93. Merck KGaA Recent Development

Table 94. Batavia Biosciences Company Details

Table 95. Batavia Biosciences Business Overview

Table 96. Batavia Biosciences Viral Vector Manufacturing CDMO Services Product

Table 97. Batavia Biosciences Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 98. Batavia Biosciences Recent Development

Table 99. SK pharmteco Inc. Company Details

Table 100. SK pharmteco Inc. Business Overview

Table 101. SK pharmteco Inc. Viral Vector Manufacturing CDMO Services Product

Table 102. SK pharmteco Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 103. SK pharmteco Inc. Recent Development

Table 104. Biovian Company Details

Table 105. Biovian Business Overview

Table 106. Biovian Viral Vector Manufacturing CDMO Services Product

Table 107. Biovian Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 108. Biovian Recent Development

Table 109. Curia Vector Technology Company Details

Table 110. Curia Vector Technology Business Overview

Table 111. Curia Vector Technology Viral Vector Manufacturing CDMO Services Product

Table 112. Curia Vector Technology Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 113. Curia Vector Technology Recent Development

Table 114. Esco Aster Company Details

Table 115. Esco Aster Business Overview

Table 116. Esco Aster Viral Vector Manufacturing CDMO Services Product

Table 117. Esco Aster Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 118. Esco Aster Recent Development

Table 119. ABL, Inc. Company Details

Table 120. ABL, Inc. Business Overview

Table 121. ABL, Inc. Viral Vector Manufacturing CDMO Services Product

Table 122. ABL, Inc. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 123. ABL, Inc. Recent Development

Table 124. Genezen Company Details

Table 125. Genezen Business Overview

Table 126. Genezen Viral Vector Manufacturing CDMO Services Product

Table 127. Genezen Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 128. Genezen Recent Development

Table 129. Pharmaron Company Details

Table 130. Pharmaron Business Overview

Table 131. Pharmaron Viral Vector Manufacturing CDMO Services Product

Table 132. Pharmaron Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 133. Pharmaron Recent Development

Table 134. Roche AG Company Details

Table 135. Roche AG Business Overview

Table 136. Roche AG Viral Vector Manufacturing CDMO Services Product

Table 137. Roche AG Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 138. Roche AG Recent Development

Table 139. FinVector Company Details

Table 140. FinVector Business Overview

Table 141. FinVector Viral Vector Manufacturing CDMO Services Product

Table 142. FinVector Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 143. FinVector Recent Development

Table 144. FUJIFILM Diosynth Biotechnologies Company Details

Table 145. FUJIFILM Diosynth Biotechnologies Business Overview

Table 146. FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing CDMO Services Product

Table 147. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 148. FUJIFILM Diosynth Biotechnologies Recent Development

Table 149. Kaneka Eurogentec S.A. (Kaneka Corporation) Company Details

Table 150. Kaneka Eurogentec S.A. (Kaneka Corporation) Business Overview

Table 151. Kaneka Eurogentec S.A. (Kaneka Corporation) Viral Vector Manufacturing CDMO Services Product

Table 152. Kaneka Eurogentec S.A. (Kaneka Corporation) Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 153. Kaneka Eurogentec S.A. (Kaneka Corporation) Recent Development

Table 154. Oxford Biomedica plc Company Details

Table 155. Oxford Biomedica plc Business Overview

Table 156. Oxford Biomedica plc Viral Vector Manufacturing CDMO Services Product

Table 157. Oxford Biomedica plc Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 158. Oxford Biomedica plc Recent Development

Table 159. Sanofi S.A. Company Details

Table 160. Sanofi S.A. Business Overview

Table 161. Sanofi S.A. Viral Vector Manufacturing CDMO Services Product

Table 162. Sanofi S.A. Revenue in Viral Vector Manufacturing CDMO Services Business (2019-2024) & (US$ Million)

Table 163. Sanofi S.A. Recent Development

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

Table 167. Authors List of This Report

List of Figures

Figure 1. Viral Vector Manufacturing CDMO Services Picture

Figure 2. Global Viral Vector Manufacturing CDMO Services Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Viral Vector Manufacturing CDMO Services Market Share by Type: 2023 VS 2030

Figure 4. Adeno-associated Virus Features

Figure 5. Lentivirus Features

Figure 6. Retrovirus Features

Figure 7. Adenovirus Features

Figure 8. Other Features

Figure 9. Global Viral Vector Manufacturing CDMO Services Market Size by Application (2024-2030) & (US$ Million)

Figure 10. Global Viral Vector Manufacturing CDMO Services Market Share by Application: 2023 VS 2030

Figure 11. Gene Therapy Case Studies

Figure 12. Vaccine Development Case Studies

Figure 13. Cell Therapy Case Studies

Figure 14. Viral Vector Manufacturing CDMO Services Report Years Considered

Figure 15. Global Viral Vector Manufacturing CDMO Services Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Viral Vector Manufacturing CDMO Services Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Viral Vector Manufacturing CDMO Services Market Share by Region: 2023 VS 2030

Figure 18. Global Viral Vector Manufacturing CDMO Services Market Share by Players in 2023

Figure 19. Global Top Viral Vector Manufacturing CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing CDMO Services as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Viral Vector Manufacturing CDMO Services Revenue in 2023

Figure 21. North America Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Viral Vector Manufacturing CDMO Services Market Share by Country (2019-2030)

Figure 23. United States Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Viral Vector Manufacturing CDMO Services Market Share by Country (2019-2030)

Figure 27. Germany Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Viral Vector Manufacturing CDMO Services Market Share by Region (2019-2030)

Figure 35. China Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Viral Vector Manufacturing CDMO Services Market Share by Country (2019-2030)

Figure 43. Mexico Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Viral Vector Manufacturing CDMO Services Market Share by Country (2019-2030)

Figure 47. Turkey Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. UAE Viral Vector Manufacturing CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Thermo Fisher Scientific Inc. Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 51. Revvity Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 52. Charles River Laboratories Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 53. AGC Inc. Group (AGC Biologics) Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 54. NorthX Biologics Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 55. Lonza Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 56. Avid Bioservices, Inc. Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 57. Exothera Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 58. Merck KGaA Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 59. Batavia Biosciences Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 60. SK pharmteco Inc. Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 61. Biovian Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 62. Curia Vector Technology Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 63. Esco Aster Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 64. ABL, Inc. Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 65. Genezen Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 66. Pharmaron Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 67. Roche AG Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 68. FinVector Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 69. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 70. Kaneka Eurogentec S.A. (Kaneka Corporation) Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 71. Oxford Biomedica plc Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 72. Sanofi S.A. Revenue Growth Rate in Viral Vector Manufacturing CDMO Services Business (2019-2024)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global mRNA CDMO Service Market Research Report 2024

Global Adeno Associated Virus AAV Vector Production CDMO Market Research Report 2024

Global Plasmid DNA CDMO Service Market Research Report 2024

Global Biopharmaceutical CDMO Service Market Research Report 2024

Global Viral Vector Development and Manufacturing Services Market Research Report 2025

Global Biopharmaceutical CDMO Market Research Report 2025

Global Cell Therapy CDMO Services Market Research Report 2025

Global Oligonucleotide Drug CDMO Services Market Research Report 2024

Global Biopharmaceutical and Bio CDMO Market Research Report 2024

Global Pharmaceutical CDMO Market Research Report 2025

Global Full Service CDMO Market Research Report 2024

Global Viral Vector Manufacturing for Gene Therapy Market Research Report 2024

Global Biologics CDMO Services Market Research Report 2024

Global Formulation CDMO Services Market Research Report 2024

Global Antibody Drug CDMO Service Market Research Report 2024

Global Oligonucleotide CDMO Market Research Report 2025

Global Chemical CDMO Market Research Report 2024

Global Contract Dose Manufacturing Market Insights Forecast to 2030

CGT CDMO Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions